Yigit, S. Et Al. 2012. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma. NEOPLASMA , vol.59, no.5 , 475-485.

Yigit, S., DEMİR, L., Tarhan, M. O., Cabuk, F. K., Ellidokuz, H., Erten, C., ... Somali, I.(2012). The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma. NEOPLASMA , vol.59, no.5, 475-485.

Yigit, S. Et Al. "The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma," NEOPLASMA , vol.59, no.5, 475-485, 2012

Yigit, S. Et Al. "The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma." NEOPLASMA , vol.59, no.5, pp.475-485, 2012

Yigit, S. Et Al. (2012) . "The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma." NEOPLASMA , vol.59, no.5, pp.475-485.

@article{article, author={S. Yigit Et Al. }, title={The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma}, journal={NEOPLASMA}, year=2012, pages={475-485} }